OASIS PHARMACEUTICALS, LLC STTR Phase II Award, February 2023
A STTR Phase II contract was awarded to OASIS PHARMACEUTICALS, LLC in February, 2023 for $999,799.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.